Bioactive natural compounds for the treatment of gastrointestinal disorders

被引：51

作者：

Ghosh, S ^{[1
]}

Playford, RJ ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Gastroenterol, Fac Med, London W12 0NN, England

来源：

CLINICAL SCIENCE | 2003年 / 104卷 / 06期

关键词：

nutriceuticals; repair; ulceration;

D O I：

10.1042/CS20030067

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Many healthy subjects and patients are taking natural bioactive products for the prevention and treatment of multiple conditions, including gastrointestinal disorders. Based on current evidence, the scientific validity of the use of many of these commercial compounds by the general public is severely limited, with quality control and regulatory issues continuing to be a concern. Nevertheless, there is sufficient preliminary data to warrant further research of these products in order to identify novel compounds for potential clinical use in addition to performing formal randomized controlled clinical trials of the commercial preparations.

引用

收藏

页码：547 / 556

页数：10

相关论文

共 95 条

[1] Treatment of achalasia:: Botulinum toxin injection vs. pneumatic balloon dilation.: A prospective study with long-term follow-up [J].

Allescher, HD ;

Storr, M ;

Seige, M ;

Gonzales-Donoso, R ;

Ott, R ;

Born, P ;

Frimberger, E ;

Weigert, N ;

Stier, A ;

Kurjak, M ;

Rösch, T ;

Classen, M .

ENDOSCOPY, 2001, 33 (12) :1007-1017

[2]

ALSOMAL NA, 1994, J ROY SOC MED, V87, P9

[3]

Amagase H, 2001, J NUTR, V131, p955S, DOI 10.1093/jn/131.3.955S

[4] Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl [J].

Anto, RJ ;

Mukhopadhyay, A ;

Denning, K ;

Aggarwal, BB .

CARCINOGENESIS, 2002, 23 (01) :143-150

[5]

Ashraf H, 2001, ACTA PAEDIATR, V90, P1373, DOI 10.1080/08035250152708743

[6]

ASLAN A, 1992, AM J GASTROENTEROL, V87, P432

[7] Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease [J].

Belluzzi, A ;

Brignola, C ;

Campieri, M ;

Pera, A ;

Boschi, S ;

Miglioli, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (24) :1557-1560

[8] Prophylactic use of epidermal growth factor reduces ischemia/reperfusion intestinal damage [J].

Berlanga, J ;

Prats, P ;

Remirez, D ;

Gonzalez, R ;

Lopez-Saura, P ;

Aguiar, J ;

Ojeda, M ;

Boyle, JJ ;

Fitzgerald, AJ ;

Playford, RJ .

AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (02) :373-379

[9] Dietary agents in cancer prevention: flavonoids and isoflavonoids [J].

Birt, DF ;

Hendrich, S ;

Wang, WQ .

PHARMACOLOGY & THERAPEUTICS, 2001, 90 (2-3) :157-177

[10] EFFECTS OF IZP-94005 (CONTIGNASTEROL) ON ANTIGEN-INDUCED BRONCHIAL RESPONSIVENESS IN OVALBUMIN-SENSITIZED GUINEA-PIGS [J].

BRAMLEY, AM ;

LANGLANDS, JM ;

JONES, AK ;

BURGOYNE, DL ;

LI, Y ;

ANDERSEN, RJ ;

SALARI, H .

BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (08) :1433-1438

← 1 2 3 4 5 6 7 8 9 10 →